3
Announcements
Trials
Browse
Landscape
Status
Unknown
4
Completed
4
Recruiting
3
Terminated
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Lymphoma, B-Cell
1
Lymphatic Metastasis
1
Leukemia
1
Head and Neck Neoplasms
1
Cardiotoxicity
1
Carcinoma, Transitional Cell
1
Breast Neoplasms
1
Atherosclerosis
1
Aggression
1
Interventions
pembrolizumab
25
Cyclophosphamide
20
Nivolumab
13
Doxorubicin
13
Carboplatin
10
Surveys and Questionnaires
9
Paclitaxel
9
Exercise
9
atezolizumab
8
Vincristine
8
Rituximab
8
Radiotherapy
8
Prednisone
8
Dexamethasone
8
Bevacizumab
8
venetoclax
7
fludarabine
7
Pemetrexed
7
Fluorouracil
7
Docetaxel
7
Blood Specimen Collection
7
lenvatinib
6
dostarlimab
6
cemiplimab
6
budigalimab
6
Oxaliplatin
6
Cisplatin
6
durvalumab
5
Leucovorin
5
Lenalidomide
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neoplasms
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT06597045
2024-09-19
BIOCAPRI
NHS Greater Glasgow and Clyde
Active not recruiting
60 enrolled